HCA Healthcare, Inc. $HCA Shares Sold by TFB Advisors LLC

TFB Advisors LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.6% in the second quarter, according to its most recent filing with the SEC. The firm owned 696 shares of the company’s stock after selling 57 shares during the quarter. TFB Advisors LLC’s holdings in HCA Healthcare were worth $267,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new position in HCA Healthcare during the 4th quarter worth $1,021,000. GAMMA Investing LLC boosted its position in HCA Healthcare by 17.6% during the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after acquiring an additional 737 shares during the period. Oppenheimer Asset Management Inc. raised its stake in shares of HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock worth $1,491,000 after buying an additional 105 shares in the last quarter. Oppenheimer & Co. Inc. raised its stake in shares of HCA Healthcare by 0.9% in the 1st quarter. Oppenheimer & Co. Inc. now owns 13,390 shares of the company’s stock worth $4,627,000 after buying an additional 121 shares in the last quarter. Finally, Asset Management One Co. Ltd. raised its stake in shares of HCA Healthcare by 1.4% in the 1st quarter. Asset Management One Co. Ltd. now owns 76,561 shares of the company’s stock worth $26,456,000 after buying an additional 1,035 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $441.08 on Thursday. The company has a market capitalization of $103.21 billion, a P/E ratio of 18.54, a price-to-earnings-growth ratio of 1.37 and a beta of 1.40. The business’s 50-day moving average price is $412.90 and its two-hundred day moving average price is $380.12. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $443.41.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is 12.11%.

Wall Street Analyst Weigh In

HCA has been the topic of a number of research reports. Mizuho boosted their price objective on HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. Jefferies Financial Group boosted their target price on HCA Healthcare from $400.00 to $485.00 in a research report on Wednesday, October 15th. Wolfe Research lowered HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a research report on Wednesday, October 8th. Finally, Truist Financial set a $460.00 target price on HCA Healthcare in a research report on Tuesday, October 14th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $437.19.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.